You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Adverse events following immunization in Ontario's female school-based HPV program
|
---|---|
Published in |
Vaccine, January 2014
|
DOI | 10.1016/j.vaccine.2014.01.004 |
Pubmed ID | |
Authors |
Tara Harris, Dawn M. Williams, Jill Fediurek, Tsui Scott, Shelley L. Deeks |
Abstract |
In September 2007, a school-based human papillomavirus (HPV) vaccination program targeting grade 8 girls (approximately 13 years old) and delivered by public health was implemented in Ontario, Canada. We assessed reports of adverse events following immunization (AEFI) from the school-based program as part of quadrivalent HPV (HPV4) vaccine safety surveillance and to contribute to a comprehensive HPV vaccine program evaluation. |
X Demographics
The data shown below were collected from the profiles of 145 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Argentina | 30 | 21% |
Canada | 15 | 10% |
United States | 10 | 7% |
Spain | 5 | 3% |
Japan | 2 | 1% |
Venezuela, Bolivarian Republic of | 2 | 1% |
Peru | 2 | 1% |
United Kingdom | 2 | 1% |
France | 1 | <1% |
Other | 6 | 4% |
Unknown | 70 | 48% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 126 | 87% |
Practitioners (doctors, other healthcare professionals) | 9 | 6% |
Scientists | 5 | 3% |
Science communicators (journalists, bloggers, editors) | 5 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Netherlands | 1 | 1% |
Belgium | 1 | 1% |
Brazil | 1 | 1% |
Unknown | 74 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 14 | 18% |
Researcher | 12 | 15% |
Student > Bachelor | 9 | 12% |
Other | 7 | 9% |
Student > Ph. D. Student | 6 | 8% |
Other | 14 | 18% |
Unknown | 16 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 34 | 44% |
Agricultural and Biological Sciences | 7 | 9% |
Social Sciences | 6 | 8% |
Nursing and Health Professions | 4 | 5% |
Psychology | 2 | 3% |
Other | 7 | 9% |
Unknown | 18 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 157. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2023.
All research outputs
#265,857
of 25,728,350 outputs
Outputs from Vaccine
#255
of 16,610 outputs
Outputs of similar age
#2,522
of 338,870 outputs
Outputs of similar age from Vaccine
#3
of 187 outputs
Altmetric has tracked 25,728,350 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,610 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 338,870 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 187 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.